verlukast and Hepatitis-C--Chronic

verlukast has been researched along with Hepatitis-C--Chronic* in 1 studies

1 other study(ies) available for verlukast and Hepatitis-C--Chronic

Article	Year
MK-571, a Cysteinyl Leukotriene Receptor 1 Antagonist, Inhibits Hepatitis C Virus Replication. Antimicrobial agents and chemotherapy, 2020, 05-21, Volume: 64, Issue:6 Topics: Antiviral Agents; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Propionates; Quinolines; Receptors, Leukotriene; Replicon; Virus Replication	2020